Therapeutic Hypothermia Systems Market Size, Share and Trends 2025 to 2034

Therapeutic Hypothermia Systems Market Size and Forecast 2025 to 2034

The global therapeutic hypothermia systems market size accounted for USD 304.12 million in 2024 and is predicted to increase from USD 318.81 million in 2025 to approximately USD 487.42 million by 2034, expanding at a CAGR of 4.83% from 2025 to 2034. The growth of the market is mainly driven by the rising awareness amongst healthcare professionals about the benefits of therapeutic hypothermia systems.

Therapeutic Hypothermia Systems Market Key Takeaways

• North America dominated the market with the largest market share of 41% in 2024.
• Asia Pacific is projected to grow at a notable CAGR during the forecast period.
• By product, the cooling devices segment accounted for the highest market share in 2024.
• By product, the cooling catheters segment is expected to grow at a significant CAGR in the coming years. 
• By application, the neurology segment led the market in 2024.
• By application, the cardiovascular segment is expected to grow at the fastest rate between 2025 and 2034.

Impact of AI on the Therapeutic Hypothermia Systems Market

Artificial intelligence significantly impacts the medical devices sector, driving innovations in therapeutic hypothermia systems. Integrating AI algorithms into therapeutic hypothermia systems helps improve the quality, accuracy, and reliability of various cooling devices. Real-time monitoring is a major benefit of AI-driven hypothermia systems. AI algorithms can help analyze the vital signs and EEG readings and automate temperature control during hypothermia therapy, further helping healthcare professionals make informed decisions.

By using AI and ML algorithms, hypothermia systems can analyze huge amounts of patient health data, which can proactively help identify potential risks associated with hypothermia therapy. AI technology can offer patients a more personalized approach to care, enabling a targeted treatment plan. AI also facilitates remote monitoring of patients undergoing hypothermia therapy. In addition, integrating AI technologies in the manufacturing processes of medical devices, including hypothermia systems, can enhance operational efficiency, maintain consistency in quality, and streamline the supply chain by managing inventory.

U.S. Therapeutic Hypothermia Systems Market Size and Growth 2025 to 2034

The U.S. therapeutic hypothermia systems market size was exhibited at USD 93.52 million in 2024 and is projected to be worth around USD 152.72 million by 2034, growing at a CAGR of 5.02% from 2025 to 2034.

North America registered dominance in the market by holding the largest share in 2024. This is mainly due to the presence of well-established healthcare infrastructure in this region. This region also boasts numerous state-of-the-art medical facilities. There is also a high adoption of sophisticated medical devices among hospitals and clinics to improve patient outcomes. The region’s developed healthcare infrastructure makes the development and adoption of therapeutic hypothermia easier.

The U.S. is a major contributor to the North American therapeutic hypothermia systems market. The easy availability and accessibility to advanced hypothermia systems are key factors supporting the market growth in the U.S. An increase in the number of incidents of traumatic brain injuries and cardiac arrest is further boosting the demand for therapeutic hypothermia systems. The country is at the forefront of technological innovations in the realm of medical devices, accelerating the development of therapeutic hypothermia systems with advanced mechanisms. Moreover, rising government investments in research and development activities contribute to market expansion.

Asia Pacific is expected to witness the fastest growth in the market during the forecast period. The rapid economic growth in several Asian countries is leading to a significant increase in healthcare spending. This, in turn, boosts the adoption of medical devices, including therapeutic hypothermia systems. Governments around the region are investing heavily to improve healthcare infrastructure and expand the accessibility of healthcare in underserved areas. The rising prevalence of cardiovascular and neurological conditions and the growing geriatric population are further boosting the demand for therapeutic hypothermia, contributing to regional market growth.

Countries like China and India are expected to play an important role in the growth of the Asia Pacific therapeutic hypothermia systems market. There is a substantial rise in investments by governments of these countries for research and development activities, as well as the development of advanced healthcare infrastructure. With the growing instances of cardiac arrest, stroke, and traumatic injuries, the demand for therapeutic hypothermia has increased in these countries. In addition, initiatives taken by the government to offer technologically advanced healthcare services support the growth of the market. 

Europe is observed to grow at a considerable growth rate in the upcoming period. This is mainly due to the region’s well-established healthcare infrastructure that supports the rapid deployment of therapeutic hypothermia systems in hospitals. Countries like Germany, France, Italy, the UK, and Spain are anticipated to play a major role in the European therapeutic hypothermia systems market. This is mainly due to the increasing focus on improving patient outcomes, leading to the rapid adoption of sophisticated medical devices, including hypothermia systems.

Market Overview

Therapeutic hypothermia systems refer to medical devices that are specifically designed for use in therapeutic hypothermia, a complex medical procedure involving lowering a patient’s body temperature to a specific range. These devices help to protect important tissues and organs from ischemic injury, manage inflammatory response, and slow down metabolic processes. These systems are embedded with different cooling methods, like water blankets, cooling devices, extracorporeal cooling systems, cooling catheters, or rapid and controlled cooling. The therapeutic hypothermia systems market is witnessing rapid growth due to the rising awareness amongst healthcare professionals regarding the benefit of these systems in reducing mortality and improving patient outcomes suffered from cardiac arrest.

The real-time feedback and provision of adjustments to cooling rates make therapeutic hypothermia systems a popular choice. These systems aid in reducing neurological damage and improve patient outcomes. Ongoing technological advancements in medical devices have enhanced the efficiency, accuracy, and reliability of these systems, supporting the growth of this market. Key players operating in the market are integrating advanced features in their existing products to improve their efficiency in patient monitoring and temperature control. Moreover, the rising number of cases of traumatic brain injuries and cardiovascular issues is boosting the growth of the market.

Therapeutic Hypothermia Systems Market Growth Factors

• The rising cases of cardiovascular conditions like cardiac arrest, stroke, and myocardial infections (MI) boost the growth of the market.
• The growing awareness about the benefits of therapeutic hypothermia systems in improving patient outcomes and long-term recovery contributes to market expansion.
• Technological advancements in medical devices and cooling methods further support market growth.
• A rise in accessibility and ease of usability of these systems led to widespread acceptance, fueling the growth of this market. 

Market Scope

Market Dynamics

Drivers

Advancements in Technology

Ongoing technological advancements are a key factor driving the growth of the therapeutic hypothermia systems market. Advances in medical device technologies led to the development of sophisticated, user-friendly therapeutic hypothermia systems. Innovative devices with advanced mechanisms, like temperature control mechanisms, help healthcare professionals maintain and regulate the temperature in a patient’s body to a specific range over a set period of time. This precision helps avoid complications during hypothermia therapy and ensures better patient outcomes. 

Moreover, emerging technologies are enhancing the convenience, effectiveness, and safety of hypothermia systems. Integrating advanced technologies, like AI and Machine Learning, enable real-time monitoring of patients undergoing hypothermia therapy. This further helps healthcare professionals make quick and informed decisions about treatment.

Restraint

Potential Side Effects and High Cost

Potential side effects associated with therapeutic hypothermia restrain the growth of the therapeutic hypothermia systems market. This procedure can lead to arrhythmias, hypotension, and bradycardia, which discourages potential patients from undergoing the procedure, significantly lowering the use of therapeutic hypothermia systems. These side effects are possible if the core temperature increases and decreases to a specific level rapidly, which can lead to serious complications. In addition, the high costs associated with these systems create barriers for healthcare facilities with budget constraints, limiting the growth of the market. 

Opportunity

Expansion into Emerging Countries

Emerging countries across the world, like China, India, Taiwan, South Korea, Brazil, Russia, and Türkiye, are experiencing rapid economic growth, creating immense opportunities for the growth of the therapeutic hypothermia systems market during the forecast period. As economic growth increases, healthcare spending increases. These countries are investing heavily in developing sophisticated healthcare infrastructure and services that provide new avenues for expanding this market.

• For instance, in December 2024, the World Bank Board approved USD 250 million in funding for Türkiye to improve the country’s readiness to handle public health emergencies. Such investments toward improving healthcare access are expected to support market growth. Moreover, the growing geriatric population is likely to propel the market's growth during the forecast period, as older adults are more prone to cardiovascular and neurological diseases.

Product Insights

The cooling devices segment dominated the therapeutic hypothermia systems market with the largest share in 2024. This is mainly due to the ease of usability and availability of cooling devices. These devices are simple and effective in regulating temperature, making them essential in hypothermia therapy. The increase in the adoption of cooling devices in cardiovascular procedures being conducted worldwide due to their cost-effectiveness further augmented the segment.

The cooling catheters segment is projected to observe significant growth during the forecast period. This is mainly due to the increasing demand for minimally invasive procedures. Cooling catheters are minimally invasive, reducing the risk of complications and patient discomfort. These catheters provide a precise approach to regulating temperature. They help by directly cooling the blood in specific vessels that further help healthcare professionals maintain the required target temperature. 

Application Insights

The neurology segment dominated the therapeutic hypothermia systems market in 2024. This is mainly due to the heightened awareness among healthcare professionals about the benefits of therapeutic hypothermia in treating several conditions, such as spinal cord injury and traumatic brain injury. Therapeutic hypothermia has proven effective in reducing complications and improving outcomes for patients with neurological conditions. The rise in the prevalence of neurological disorders worldwide further bolstered the segmental growth.

On the other hand, the cardiology segment is expected to witness the fastest growth during the forecast period. The rising number of cases of cardiovascular diseases and a growth in the number of procedures related to cardiovascular diseases are significantly boosting the demand for therapeutic hypothermia systems. Therapeutic hypothermia reduces the mortality rate among patients who have experienced cardiac arrest or stroke.

Therapeutic Hypothermia Systems Market Companies

• Asahi Kasei Corporation
• Audax Management Company, LLC.
• Belmont Medical Technologies
• BrainCool AB
• ZOLL Medical Corporation
• Becton, Dickinson, and Company
• Stryker Corporation
• EM-MED Sp. z o.o.
• Life Recovery Systems
• Drägerwerk AG & Co. KgaA
• Terumo Cardiovascular Systems Corporation
• pfm medical gmbh

Recent Developments

• In November 2024, an established manufacturer of medical devices, Zoll Medical Corp., announced a plan to purchase the InterCool temperature management business from Philips Healthcare. This acquisition helps Zoll enhance the product portfolio, including catheter-based endovascular and surface temperature management technologies, to improve patient outcomes.
• In January 2024, SourceMark Medical announced the expansion of its partnership with Gentherm Medical, a well-known manufacturer of patient temperature management systems.

Segments Covered in the Report

By Product

• Cooling Catheters
• Water Blankets
• Cool Caps
• Cooling Devices

By Application

• Neurology
• Cardiology
• Neonatal Care
• Others

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)